Press release
Global Biomarker Clinical Phase Outsourcing Services Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Biomarker Clinical Phase Outsourcing Services
How Big Is the Biomarker Clinical Phase Outsourcing Services Market Size Expected to Be by 2034?
The biomarker clinical phase outsourcing services market has grown exponentially in recent years. It is expected to increase from $9.71 billion in 2024 to $11.94 billion in 2025, at a compound annual growth rate (CAGR) of 23.0%. This growth is driven by rising government initiatives and funding, increasing diagnostic applications of biomarkers, a rise in research and development funding, rapid advancements in technologies like genomics, proteomics, and imaging, and the growing demand for cancer biomarkers.
The biomarker clinical phase outsourcing services market is expected to reach $27.09 billion by 2029 at a CAGR of 22.7%. This growth is attributed to the increasing use of biomarkers in clinical trials, expanding precision medicine demand, companion diagnostics adoption, and personalized medicine. Major trends include advanced trial parameters, diagnostic-focused phases, biomarker technology advancements, government initiatives, and technology progress.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15740
What Are the Emerging Segments Within the Biomarker Clinical Phase Outsourcing Services Market?
The biomarker clinical phase outsourcing services market covered in this report is segmented -
1) By Type: Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types
2) By Service Type: Biomarker Validation, Biomarker Testing Services, Biomarker Sample Analysis
3) By Therapeutic Area: Oncology, Neurology, Cardiology, Autoimmune Diseases, Other Therapeutic Areas
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions
Subsegments:
1) By Surrogate Endpoints: Tumor Marker-Based Endpoints, Imaging-Based Endpoints, Genetic or Genomic Markers
2) By Predictive Biomarker: Genetic Predictive Biomarkers, Protein Predictive Biomarkers, Metabolomic Predictive Biomarkers
3) By Prognostic Biomarker: Cancer Prognostic Biomarkers, Cardiovascular Prognostic Biomarkers, Neurological Prognostic Biomarkers
4) By Safety Biomarker: Toxicity Biomarkers, Adverse Drug Reaction Biomarkers, Drug Interaction Biomarkers
5) By Other Biomarker Types: Inflammation Biomarkers, Infectious Disease Biomarkers, Autoimmune Disease Biomarkers
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15740&type=smp
What Long-Term Drivers Are Shaping Biomarker Clinical Phase Outsourcing Services Market Trends?
The increase in clinical trials is expected to propel the biomarker clinical phase outsourcing services market. Clinical trials are essential for evaluating the safety and effectiveness of medical treatments. The rise in trials is driven by medical research advancements, the prevalence of chronic diseases, and increased funding. Outsourcing services with expertise in biomarker discovery and analysis improve the quality and reliability of data during trials. In May 2023, the U.S. National Library of Medicine reported an increase in registered clinical trials from 399,499 in 2022 to 437,533 in 2023. This increase in clinical trials will drive the biomarker clinical phase outsourcing services market.
Who Are the Top Competitors in Key Biomarker Clinical Phase Outsourcing Services Market Segments?
Major companies operating in the biomarker clinical phase outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC
What Trends Are Expected to Dominate the Biomarker Clinical Phase Outsourcing Services Market in the Next 5 Years?
Major companies in the biomarker clinical phase outsourcing services are advancing high-throughput flow cytometry and ELISpot testing to improve their market position. These technologies enable rapid and precise immune response and cellular marker assessments. For example, in November 2022, Celerion Inc., a US-based biotechnology outsourcing firm, expanded its services to include GLP/GCP-compliant molecular and cell biology testing, aiming to enhance its support throughout the drug development process, from early clinical research to regulatory submissions. This expansion allows Celerion to offer more comprehensive services, including pharmacokinetic, pharmacodynamic, and biomarker analysis, helping clients meet regulatory standards and accelerate new medicine development.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/biomarker-clinical-phase-outsourcing-services-global-market-report
Which Regions Are Becoming Hubs for Biomarker Clinical Phase Outsourcing Services Market Innovation?
North America was the largest region in the biomarker clinical phase outsourcing services market in 2023. The regions covered in the biomarker clinical phase outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Biomarker Clinical Phase Outsourcing Services Market?
2. What is the CAGR expected in the Biomarker Clinical Phase Outsourcing Services Market?
3. What Are the Key Innovations Transforming the Biomarker Clinical Phase Outsourcing Services Industry?
4. Which Region Is Leading the Biomarker Clinical Phase Outsourcing Services Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biomarker Clinical Phase Outsourcing Services Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 4035222 • Views: …
More Releases from The Business Research Company
Emerging Trends Influencing The Growth Of The Blind Spot Monitor Market: Next-Ge …
The Blind Spot Monitor Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Blind Spot Monitor Market Size Expected to Be by 2034?
The blind spot monitor market size has grown rapidly in recent years. It will expand from $15.93 billion in 2024…
Enhancing Security And Convenience In Cash Withdrawals Driving Growth In The Bio …
The Biometric Automated Teller Machine (ATM) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Biometric Automated Teller Machine (ATM) Market Size and Its Estimated Growth Rate?
The biometric automated teller machine (ATM) market has experienced strong growth in recent years. It is…
Cruise Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunitie …
The Cruise Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Cruise Market?
The cruise market has grown rapidly in recent years. It will grow from $7.82 billion in 2024 to $8.82 billion in 2025, at a CAGR of 12.7%.…
Global Bitcoin Technology Market Analysis 2025-2030: Growth Drivers, Challenges, …
The Bitcoin Technology Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Bitcoin Technology Market Size Expected to Be by 2034?
The bitcoin technology market size has seen rapid growth in recent years. It is expected to increase from $16.99 billion in 2024…
More Releases for Biomarker
Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF (including full…
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the…
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period.
A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis…
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core…
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports.
The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and…
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological…
